Zobrazeno 1 - 10
of 538
pro vyhledávání: '"Manfredi Rizzo"'
Autor:
Roopa Koshy McCall, Hamed Al-Sinawi, Nutaila Al-Kharusi, Sulaiman Al Rawahi, Rola Al Balushi, Nabil Al-Lawati, Manfredi Rizzo, Khalid Al-Rasadi, Abdullah Al Maniri
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
OverviewTo combat the overwhelming demand for medical services and care during the COVID-19 Pandemic, the Sultanate of Oman launched the COVID-19 Field Hospital in 2020, designed to respond and alleviate the burden on the medical infrastructure. Seve
Externí odkaz:
https://doaj.org/article/e461bca7409941c4ad2e63dc128722e0
Autor:
Khamis Al Hashmi, Rosaria Vincenza Giglio, Anca Pantea Stoian, Angelo Maria Patti, Khalid Al Waili, Khalid Al Rasadi, Marcello Ciaccio, Manfredi Rizzo
Publikováno v:
Frontiers in Nutrition, Vol 11 (2024)
The definition of “Metabolic Associated Fatty Liver Disease – MAFLD” has replaced the previous definition of Nonalcoholic Fatty Liver Disease (NAFLD), because cardiometabolic criteria have been added for the prevention of cardiological risk in
Externí odkaz:
https://doaj.org/article/2d6aabb8e4784b0884bcb2b07aaf7f0b
Autor:
Panagiotis Stachteas, Paschalis Karakasis, Dimitrios Patoulias, Francesco Clemenza, Nikolaos Fragakis, Manfredi Rizzo
Publikováno v:
Annals of Medicine, Vol 55, Iss 2 (2023)
AbstractBackground Despite the widespread use of classical cholesterol-lowering drugs to mitigate the adverse impacts of dyslipidaemia on atherosclerosis, many patients still face a substantial residual risk of developing atherosclerotic cardiovascul
Externí odkaz:
https://doaj.org/article/7ee17732788640c4b6f69f05c356236c
Autor:
Karl Aramouni, Roland K. Assaf, Maria Azar, Karen Jabbour, Abdullah Shaito, Amirhossein Sahebkar, Assaad A. Eid, Manfredi Rizzo, Ali H. Eid
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Atherosclerosis is a major instigator of cardiovascular disease (CVD) and a main cause of global morbidity and mortality. The high prevalence of CVD calls for urgent attention to possible preventive measures in order to curb its incidence. Traditiona
Externí odkaz:
https://doaj.org/article/3d0461f8f2f043eba7b2b63c71d69496
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 14, Iss 1, Pp 1-6 (2022)
Abstract Glucagon (traditional kits for intramuscular administration, Glucagon and Glucagen), although recommended as a remedy for severe hypoglycemia (SH), has been reported to be under-utilized, likely because of technical problems. The aims of thi
Externí odkaz:
https://doaj.org/article/c9460d2094f84dda8cefb3781cd68d7a
Autor:
Maciej Banach, Stanisław Surma, Zeljko Reiner, Niki Katsiki, Peter E. Penson, Zlatko Fras, Amirhossein Sahebkar, Francesco Paneni, Manfredi Rizzo, John Kastelein
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-10 (2022)
Abstract Dyslipidemia in patients with type 2 diabetes (DMT2) is one of the worst controlled worldwide, with only about 1/4 of patients being on the low-density lipoprotein cholesterol (LDL-C) target. There are many reasons of this, including physici
Externí odkaz:
https://doaj.org/article/464fdc478f9b4d84b59c7b59037f54e3
Autor:
Rajashree Patnaik, Shirin Jannati, Bala Mohan Sivani, Manfredi Rizzo, Nerissa Naidoo, Yajnavalka Banerjee
Publikováno v:
JMIR Research Protocols, Vol 12, p e42964 (2023)
BackgroundChondrocytes are the primary cells responsible for maintaining cartilage integrity and function. Their role in cartilage homeostasis and response to inflammation is crucial for understanding the progression and potential therapeutic interve
Externí odkaz:
https://doaj.org/article/5889e7fd36a1489f81087b14c09a57b3
Autor:
Iman Rahnama, Seyyed Mostafa Arabi, Mahla Chambari, Leila Sadat Bahrami, Vahid Hadi, Sayid Mahdi Mirghazanfari, Manfredi Rizzo, Saeid Hadi, Amirhossein Sahebkar
Publikováno v:
Pharmacological Research, Vol 193, Iss , Pp 106802- (2023)
Background: Cardiovascular diseases (CVD) are one of the most important causes of death worldwide. Dyslipidemia is one of the main causal risk factors for CVD that can be controlled by modifying lifestyle, which entails the use of healthy diets conta
Externí odkaz:
https://doaj.org/article/77bc783e48c3437684ad3952bf899ef7
Autor:
Rosaria Vincenza Giglio BD, PhD, Emir M. Muzurović MD, PhD, Angelo Maria Patti MD, PhD, Peter P. Toth MD, PhD, Manyoo A. Agarwal MD, Wael Almahmeed MD, Aleksandra Klisic MD, PhD, Marcello Ciaccio MD, PhD, Manfredi Rizzo MD, PhD
Publikováno v:
Journal of Cardiovascular Pharmacology and Therapeutics, Vol 28 (2023)
Background: Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) are low-density lipoprotein cholesterol (LDL-C)-lowering drugs that play a critical role in lipoprotein clearance and metabolism. PCSK9i are used in patients with familial
Externí odkaz:
https://doaj.org/article/faa1eeb0bb4341d0aad3475c053e45d6
Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement
Autor:
Laszlo Rosta, Adrienn Menyhart, Wael Al Mahmeed, Khalid Al-Rasadi, Kamila Al-Alawi, Maciej Banach, Yajnavalka Banerjee, Antonio Ceriello, Mustafa Cesur, Francesco Cosentino, Alberto Firenze, Massimo Galia, Su-Yen Goh, Andrej Janez, Sanjay Kalra, Nitin Kapoor, Nader Lessan, Paulo Lotufo, Nikolaos Papanas, Ali A. Rizvi, Amirhossein Sahebkar, Raul D. Santos, Anca Pantea Stoian, Peter P. Toth, Vijay Viswanathan, Peter Kempler, Manfredi Rizzo
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
The past two decades have witnessed telemedicine becoming a crucial part of health care as a method to facilitate doctor-patient interaction. Due to technological developments and the incremental acquisition of experience in its use, telemedicine’s
Externí odkaz:
https://doaj.org/article/56dc1442c17e496cb6dbb806b8193e00